Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistance

Ozyerli-Goknar E, et al.

Citation

Blood. 2026 Jun 29:blood.2025032363.

PMID

42371796